Merck's $688M Vytorin Settlement Wins Judge's Nod
A New Jersey federal judge on Tuesday approved a $688 million settlement to settle claims that Merck & Co. Inc. and its subsidiary Schering-Plough Corp. concealed test results on the efficacy...To view the full article, register now.
Already a subscriber? Click here to view full article